| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Johnson David Michael serves as a Director at ZNTL and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 25 buys and 8 sells.
Historically, Johnson David Michael's trades have earned a middling insider score of 59/100 across 14 rated trades. Over a 12-month horizon, 42.9% of those trades were profitable, with an average 12-month return of +1.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 12,896 | $51.39 | $662,746.59 | -11.2% | |
| Apr 7, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Buy | 4,000 | $18.00 | $72,000.00 | +3.6% |